knowledge -WSS

knowledge

author：comprehensive 2025-10-01 00:48:52 - browse：915

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Experts study whether long Covid risk adds up with each reinfection

hotspot

WSS

Stop Congress from blocking public access to science

Health insurers' Q3 question: how much care are people getting?

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

The biotech scorecard for Q4: 16 stock

Nobel honors Karikó and Weissman's enduring partnership

Gene therapy has helped boys walk. Can scientists keep it that way?

Wikipedia

knowledge

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Paxlovid study fails to answer questions over benefit for broader groups

How to save PrEP access — and even expand it

6 solutions to address cancer drug shortages and others

Moonlake's readout produced a cash windfall. Risks remain

The biotech scorecard for Q4: 16 stock

Activists slam private health insurers over coverage restrictions

What would happen to your eyes if you looked at the solar eclipse?

BioMarin wins approval for gene therapy to treat hemophilia A

Disclosing genetic information: not as worrisome as once feared

hotspot

The battle over the Brookhaven Landfill on Long Island

What would happen to your eyes if you looked at the solar eclipse?

Nobel honors Karikó and Weissman's enduring partnership

Donald Trump's relentless attacks on special counsel Jack Smith

6 solutions to address cancer drug shortages and others

Donald Trump's relentless attacks on special counsel Jack Smith

hotspot

hotspot

focus

hotspot